Neoantigens Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

The Global Neoantigens Market is expected to reach US$ 10,54,783.54 thousand by 2028 from US$ 2,71,428.57 thousand in 2020. It is estimated to grow at a CAGR of 18% during 2021-2027.

Neoantigens are known as newly formed antigens that were not previously recognized by the immune system. Oncoprotein alterations can lead to the formation of neoantigens formed as a result of tutor mutations or viral proteins. Neoantigens are used in targeted therapies for the treatment of cancer cells. It is also tumor specific and highly immunogenic. Therefore, neoantigens are not expressed in healthy tissues. Neoantigens play an important role in tumor-specific T cell-mediated antitumor responses and cancer immunotherapy. Research also suggests that neoantigens may also play important roles in immune escape, immune editing, and susceptibility to immune checkpoint inhibitors.

Market Segments

By Treatment

• Combination Therapy
• Mono Therapy

By Therapeutic Specialty

• Gastrointestinal Cancer
• Lung Cancer
• Solid Tumors
• Urinary System Cancers
• Melanoma
• Head and Neck Cancer

Key Players

• Achilles Therapeutics plc
• Advaxis, Inc.
• Frame Cancer Therapeutics
• Genocea, Gradalis, Inc.
• Gritstone Oncology
• Immunicum AB
• Medigene AG
• Ziopharm Oncology, Inc.

Scope of the Report

The research study analyzes the global Neoantigens industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Neoantigens Market Report

1. What was the Neoantigens Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of the Neoantigens Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Neoantigens Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.